Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Assembly Biosciences Inc. (ASMB)

16.57   0.48 (2.98%) 04-18 16:00
Open: 16.07 Pre. Close: 16.09
High: 16.63 Low: 15.715
Volume: 500,202 Market Cap: 423M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.644 - 16.762 16.762 - 16.853
Low: 15.508 - 15.628 15.628 - 15.722
Close: 16.407 - 16.6 16.6 - 16.75

Technical analysis

as of: 2019-04-18 4:34:21 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 21.17     One year: 24.77
Support: Support1: 13.13    Support2: 10.92
Resistance: Resistance1: 18.12    Resistance2: 21.21
Pivot: 18.73
Moving Average: MA(5): 16.50     MA(20): 18.70
MA(100): 21.29     MA(250): 30.58
MACD: MACD(12,26): -0.91     Signal(9): -0.56
Stochastic oscillator: %K(14,3): 39.32     %D(3): 35.38
RSI: RSI(14): 39.58
52-week: High: 48.91  Low: 13.13  Change(%): -64.6
Average Vol(K): 3-Month: 31298  10-Days: 71184

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ASMB has closed above bottom band by 20.1%. Bollinger Bands are 57.6% wider than normal. The large width of the bands suggest high volatility as compared to ASMB's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Mon, 15 Apr 2019 19:10:13 Z
Here's Why Assembly Biosciences Is Slipping Today

Mon, 15 Apr 2019 19:06:54 Z
Monday Sector Laggards: Biotechnology, Drugs

Mon, 15 Apr 2019 13:46:41 Z
Health Care Sector Update for 04/15/2019: ASMB, APHA, CLVS, JNJ, PFE, MRK, ABT, AMGN

Wed, 20 Feb 2019 06:06:52 Z
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects

Thu, 31 Jan 2019 16:57:37 Z
Mylan (MYL) Jumps: Stock Rises 7.1%

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25.55
Shares Float (M) 23.64
% Held by Insiders
% Held by Institutions 117.70
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -4.000
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS -2.351
Book Value (p.s.) 2.490
PEG Ratio -0.26
Profit Margin
Operating Margin -597.37
Return on Assets (ttm) -42.2
Return on Equity (ttm) -56.9
Qtrly Rev. Growth 12.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -64.96
Levered Free Cash Flow (M) -22.75

Stock Valuations

P/E -4.14
P/E Growth Ratio 0.03
P/BV 6.65
P/S 651328448.00
P/CF -6.52

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-07-14
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.